Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomodulators and TPO-RAs in Primary ITP with Hemorrhage
NCT05861297Phase 4Unknown
- Sponsor
- Nahda University
- Start
- May 2020
- Primary completion
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of azathioprine, rituximab, eltrombopag, romiplostim in immune thrombocytopenia (ITP), sponsored by Nahda University. Status: unknown.
02
Drugs
azathioprinerituximabeltrombopagromiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05861297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05861297.